Charles R. Cantor, Ph.D.
SEQUENOM, Inc.
3595 John Hopkins Court
San Diego, CA 92121 USA
T: 1-858-202-9012
ccantor@sequenom.com


Charles Cantor is a founder, and Chief Scientific Officer at SEQUENOM, Inc. He is also founder of SelectX Pharmaceuticals, a drug discovery company based in the Boston area; Retrotope, an anti-aging company; and DiThera, a biotherapeutic company. He is professor emeritus of Biomedical Engineering at Boston University, adjunct professor of bioengineering at UCSD, adjunct professor of Molecular Biology at the Scripps Institute for Research and distinguished adjunct professor of Physiology and Biophysics at UC Irvine. Dr. Cantor has held positions at Columbia University and University of California at Berkeley, and was also director of the Human Genome Center of the Department of Energy at Lawrence Berkeley Laboratory. He has published more than 450 peer-reviewed articles, has been granted more than 60 patents. He co-authored a three-volume textbook on Biophysical Chemistry and the first textbook on Genomics: The Science and Technology of the Human Genome Project. He sits on the advisory boards of more than 15 national and international organizations and is a member of the National Academy of Sciences.
  Close